Recursion Pharmaceuticals
RXRX
#4101
Rank
โ‚น188.84 B
Marketcap
โ‚น485.73
Share price
-4.80%
Change (1 day)
-10.86%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น17.05 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น17.05 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น15.83 B-11.17%
2022-12-31โ‚น17.83 B255.4%
2021-12-31โ‚น5.01 B-86.41%
2020-12-31โ‚น36.92 B129.42%
2019-12-31โ‚น16.09 B